Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Immunology of neuromyelitis optica: a T cell-B cell collaboration.
Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis.
Unusual Presentation of Guillain-Barré Syndrome After Mandibular Fracture Treatment: A Review of the Literature and a New Case.
Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.
Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.
Alternating Ptosis Associated with Asialo-GM1 and GD1b Antibodies.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Ion Channels in Neurological Disorders.
Nano- and micro-based systems for immunotolerance induction in Multiple Sclerosis.
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline.
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Functions of NOD-Like Receptors in Human Diseases.
Health status, work impediments, and coping related to work roles of women with multiple sclerosis.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
The central role of mitochondria in axonal degeneration in multiple sclerosis.
Pages
« first
‹ previous
…
438
439
440
441
442
443
444
445
446
…
next ›
last »